{
    "id": 19621,
    "fullName": "ERBB2 L869Q",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ERBB2 (HER2) L869Q lies within the protein kinase domain of the Erbb2 (Her2) protein (UniProt.org). L869Q has been identified in the scientific literature (PMID: 26487584, PMID: 27602491, PMID: 28274957), but has not been biochemically characterized and therefore, its effect on Erbb2 (Her2) protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 9156,
                    "pubMedId": 28274957,
                    "title": "An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28274957"
                },
                {
                    "id": 4844,
                    "pubMedId": 26487584,
                    "title": "A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26487584"
                },
                {
                    "id": 10697,
                    "pubMedId": 27602491,
                    "title": "ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27602491"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2064,
        "geneSymbol": "ERBB2",
        "terms": [
            "ERBB2",
            "CD340",
            "HER-2",
            "HER-2/neu",
            "HER2",
            "MLN 19",
            "NEU",
            "NGL",
            "TKR1"
        ]
    },
    "variant": "L869Q",
    "createDate": "03/14/2016",
    "updateDate": "10/21/2019",
    "referenceTranscriptCoordinates": {
        "id": 170623,
        "transcript": "NM_004448",
        "gDna": "chr17:g.39725161T>A",
        "cDna": "c.2606T>A",
        "protein": "p.L869Q",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5027,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, treatment with the combination of Tykerb (lapatinib) and Xeloda (capecitabine) resulted in prolonged response and reduction in liver metastasis in a metastatic breast cancer patient harboring ERBB2 L869Q and CDH1 R63* mutations (PMID: 26487584).",
            "molecularProfile": {
                "id": 20031,
                "profileName": "CDH1 R63* ERBB2 L869Q"
            },
            "therapy": {
                "id": 1399,
                "therapyName": "Capecitabine + Lapatinib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 4844,
                    "pubMedId": 26487584,
                    "title": "A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26487584"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20030,
            "profileName": "ERBB2 L869Q",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 20031,
            "profileName": "CDH1 R63* ERBB2 L869Q",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 170623,
            "transcript": "NM_004448",
            "gDna": "chr17:g.39725161T>A",
            "cDna": "c.2606T>A",
            "protein": "p.L869Q",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 170624,
            "transcript": "NM_001289937",
            "gDna": "chr17:g.39725161T>A",
            "cDna": "c.2606T>A",
            "protein": "p.L869Q",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}